Dexcom's Apple Watch app will be ready to go when the device launches in April, the company told the Wall Street Journal. The app, which will not need to seek pre-market approval from the FDA thanks to a recent reclassification, will allow the Apple Watch to serve as a secondary display device for the Dexcom G4 (and upcoming G5) continuous glucose monitor system. The primary display will remain...
The Dexcom G4 receiver, which will have an "identical" form factor to the forthcoming Bluetooth version.
In a call to investors days after its app won FDA approval, Dexcom CEO Kevin Sayer shared some of the company's follow-up plans for its new smartphone-connected continuous glucose monitor, including Android and smartwatch apps and apps that will run some analytics on the CGM data.
Dexcom...
The old Dexcom Share, with charging cradle.
Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor data to be transferred directly to a user's smartphone, as well as the smartphones of up to five friends or caretakers.
Dexcom Share got clearance in...
The Dexcom G4 was the continuous glucose monitor used in the study.
An artificial pancreas system -- consisting of a continuous glucose monitor, and insulin pump, and an iPhone 4s -- has been shown to improve glucose regulation in a simulated outpatient setting in both adults and adolescents with Type 1 diabetes, according to a new paper in the New England Journal of Medicine. The adult...
